Kristien Boelaert

131 - 140 out of 170Page size: 10

Publications

  1. 2004
  2. Published

    Relationship between PTTG expression and genomic instability in differentiated thyroid cancers

    Dae Kim, Kristien Boelaert, Jayne Franklyn & Christopher McCabe, 1 Jan 2004.

    Research output: Contribution to conference (unpublished) › Paper

  3. Published

    Simple clinical and biochemical parameters predict thyroid neoplasia and malignancy in 1500 patients investigated by FNAB

    Kristien Boelaert, Roger Holder, Michael Sheppard & Jayne Franklyn, 1 Jan 2004.

    Research output: Contribution to conference (unpublished) › Paper

  4. Published

    The expression of MCT8, as a specific thyroid hormone transporter, in human fetal brain and placenta: the effects of IUGR

    Shiaoyng Chan, Christopher McCabe, Kristien Boelaert, Jayne Franklyn & Mark Kilby, 1 Jan 2004, p. OC9.

    Research output: Contribution to conference (unpublished) › Abstract

  5. Published

    The key mitotic regulators securin and separase in the human fetal brain

    Kristien Boelaert, Dae Kim, Lesley Tannahill, Farhat Khanim, Neil Gittoes, Jayne Franklyn, Mark Kilby & Christopher McCabe, 1 Jan 2004, p. P3-350.

    Research output: Contribution to conference (unpublished) › Abstract

  6. 2003
  7. Published

    A potential role for PTTG/securin in the developing human fetal brain

    Kristien Boelaert, Lesley Tannahill, Kachilele-Linjewile Kachilele, Shiaoyng Chan, Neil Gittoes, Jo Bradwell, Jayne Franklyn, Mark Kilby & Christopher McCabe, 1 Sep 2003, In: FASEB Journal. 17, 12, p. 1631-1639 9 p.

    Research output: Contribution to journal › Article

  8. Published

    Placental iodothyronine deiodinase expression in normal and growth restricted human pregnancies

    Shiaoyng Chan, Kachilele-Linjewile Kachilele, Emma Hobbs, Kristien Boelaert, Christopher McCabe, Philip Driver, Jayne Franklyn & Mark Kilby, 1 Sep 2003, In: Journal of Clinical Endocrinology and Metabolism. 88, 9, p. 4488-4495 8 p.

    Research output: Contribution to journal › Article

  9. Published

    Pituitary tumour transforming gene and fibroblast growth factor 2 expression: potential prognostic indicators in differentiated thyroid cancer

    Kristien Boelaert, Christopher McCabe, Lesley Tannahill, Neil Gittoes, Roger Holder, Jo Bradwell, Michael Sheppard & Jayne Franklyn, 1 May 2003, In: Journal of Clinical Endocrinology and Metabolism. 88, 5, p. 2341-2347 7 p.

    Research output: Contribution to journal › Article

  10. Published

    Abnormal expression of 11beta-HSD type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation

    Elizabeth Rabbitt, John Ayuk, Kristien Boelaert, Michael Sheppard, Martin Hewison, Paul Stewart & Neil Gittoes, 20 Mar 2003, In: Oncogene. 22(11), 11, p. 1663-1667 5 p.

    Research output: Contribution to journal › Article

  11. Published

    Sodium iodide symporter: a novel strategy to target breast, prostate, and other cancers?

    Kristien Boelaert & Jayne Franklyn, 8 Mar 2003, In: Lancet. 361, 9360, p. 796-797 2 p.

    Research output: Contribution to journal › Review article

  12. Published

    Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.

    Christopher McCabe, Kristien Boelaert, Lesley Tannahill, Shakir Hussain, Michael Sheppard, Jayne Franklyn & Neil Gittoes, 1 Feb 2003, In: Clinical Endocrinology. 58, 2, p. 141-50 10 p.

    Research output: Contribution to journal › Article

Previous 1...10 11 12 13 14 15 16 17 Next